CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | JENKINS GEORGE M Director | Purchase | +4,000 | $125.00 | $500K | 187,171 |
| 2026-02-27 | HERON ELAINE J Director | Purchase | +2,400 | $125.00 | $300K | 47,812 |
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −3,026 | $79.16 | $240K | 1,276 |
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,276 | $79.97 | $102K | 0 |
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 17,243 | ||
| 2026-02-18 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 17,184 | ||
| 2026-02-05 | Martini Jeffrey S Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +64,318 | 64,318 | ||
| 2026-02-05 | Kline Ashley Hartmann Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +38,517 | 38,517 | ||
| 2026-02-05 | Kaupinen Wes President and CEO | Grant or award · Stock Option (Right to Buy) | +124,603 | 124,603 | ||
| 2026-02-05 | Korenberg Matthew E CFO, Treasurer | Grant or award · Stock Option (Right to Buy) | +44,123 | 44,123 | ||
| 2026-02-05 | Goin Kathleen Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +48,956 | 48,956 | ||
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −553 | $95.49 | $53K | 3,749 |
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −3,749 | $97.94 | $367K | 0 |
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 19,397 | ||
| 2026-01-21 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 19,332 | ||
| 2025-12-17 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
Page 7 of 12 · 232 trades